Description 5-Amino-1MQ 50 mg is supplied as a research-grade vial option with 50 mg for controlled laboratory handling and product documentation
Results vary by individual and treatment adherence
This effect does not impact the quality or purity of the peptide
References Hsieh MJ, Liu HT, Wang CN, et al
Across all three, the protocols may not be suitable in pregnancy or breastfeeding, for those under 18, or where there are severe untreated medical conditions, and BPC-157 also lists active or recent cancer as a contraindication
If you are taking certain prescribed medication or chemotherapy, check with your GP or pharmacist to ensure this supplement is appropriate for you